HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism
HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism
Active, not recruiting · NCT02354079 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, cardiovascular disorder, hereditary disease, hypobetalipoproteinemia, hypolipoproteinemia, inborn errors of metabolism, metabolic disease | Active, not recruiting | Not applicable | 2026-04-29 | NCT02354079 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nantes University Hospital | 223 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chu de Nantes | Nantes | France | 72 |